Work

Reduction in platelet counts as a mechanistic biomarker and guide for adaptive dose-escalation in phase I studies of the Bcl-2 family inhibitor ABT-263

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.3542

Authors: A. Roberts, L. Gandhi, O. A. O'Connor, C. M. Rudin, D. Khaira, H. Xiong, Y. Chiu, R. Greco, A. P. Krivoshik, W. H. Wilson

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2243608423

Cites:

Cited by: 15

Related to: 10